Health economic evaluation of the 'DELIVER-CARE' study: a randomized controlled trial on delegation for chronic inflammatory diseases

Given the increasing shortage of medical specialists in Germany, delegating selected physician tasks to nurses has been proposed to maintain care quality for patients with chronic inflammatory diseases (CID). This study evaluated the health economic impact of a nurse-led care (NLC) model, in which nurses conducted structured, delegated consultations, compared with standard specialist care, within the Deliver-Care randomized controlled trial. This trial, conducted between 2020 and 2023 at 56 specialist outpatient practices and hospital clinics, randomized 602 patients with rheumatological, gastroenterological, or dermatological CID to the intervention group (IG, n = 295) or control group (CG, n = 307). Healthcare costs (FIMA questionnaire) were assessed at baseline and 12 months, and EQ-5D-based utility values at baseline, 6 and 12 months. Analyses followed the intention-to-treat principle, with missing data handled using multiple imputation. Group differences in costs were assessed using generalized estimating equations, and cost-effectiveness was evaluated using bootstrapping (5,000 replications) and cost-effectiveness acceptability curves. Mean total costs at 12 months were €12,061 (IG) versus €13,601 (CG), a non-significant difference (p = 0.286), with no significant group-by-time interaction. QALY gains were comparable between groups (IG: 0.80; CG: 0.78). The intervention was dominant in 87.2% of bootstrap replications, with a 94% probability of cost-effectiveness at a willingness-to-pay threshold of €50,000 per QALY. While no significant reduction in healthcare costs or improvement in quality of life were observed, the NLC model showed a high probability of cost-effectiveness, suggesting it may serve as a cost-neutral to potentially cost-saving alternative to standard care.

Authors

Institutions

Publication Details

Journal
The European Journal of Health Economics
Published
2026-11-21
DOI
https://doi.org/10.1007/s10198-026-02015-1
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Health economic evaluation of the 'DELIVER-CARE' study: a randomized controlled trial on delegation for chronic inflammatory diseases

Tim Schikowski, Torsten Witte, Franziska Püschner, Juliane Schiller et al.
The European Journal of Health Economics
Health Systems, Economic Evaluations, Quality of Life
article

Health economic evaluation of the 'DELIVER-CARE' study: a randomized controlled trial on delegation for chronic inflammatory diseases

Tim Schikowski, Torsten Witte, Franziska Püschner, Juliane Schiller, Luisa Licker, Kirsten Hoeper, Jan Zeidler, Volker Eric Amelung, Dirk Meyer-Olson
article en

Abstract

Given the increasing shortage of medical specialists in Germany, delegating selected physician tasks to nurses has been proposed to maintain care quality for patients with chronic inflammatory diseases (CID). This study evaluated the health economic impact of a nurse-led care (NLC) model, in which nurses conducted structured, delegated consultations, compared with standard specialist care, within the Deliver-Care randomized controlled trial. This trial, conducted between 2020 and 2023 at 56 specialist outpatient practices and hospital clinics, randomized 602 patients with rheumatological, gastroenterological, or dermatological CID to the intervention group (IG, n = 295) or control group (CG, n = 307). Healthcare costs (FIMA questionnaire) were assessed at baseline and 12 months, and EQ-5D-based utility values at baseline, 6 and 12 months. Analyses followed the intention-to-treat principle, with missing data handled using multiple imputation. Group differences in costs were assessed using generalized estimating equations, and cost-effectiveness was evaluated using bootstrapping (5,000 replications) and cost-effectiveness acceptability curves. Mean total costs at 12 months were €12,061 (IG) versus €13,601 (CG), a non-significant difference (p = 0.286), with no significant group-by-time interaction. QALY gains were comparable between groups (IG: 0.80; CG: 0.78). The intervention was dominant in 87.2% of bootstrap replications, with a 94% probability of cost-effectiveness at a willingness-to-pay threshold of €50,000 per QALY. While no significant reduction in healthcare costs or improvement in quality of life were observed, the NLC model showed a high probability of cost-effectiveness, suggesting it may serve as a cost-neutral to potentially cost-saving alternative to standard care.

The European Journal of Health Economics
Leibniz University Hannover (DE), Medizinische Hochschule Hannover (DE), St. Marien Hospital (DE), Hannover Re (Germany) (DE), Harz University of Applied Sciences (DE)
Gottfried Wilhelm Leibniz Universität Hannover, Gemeinsame Bundesausschuss
Good health and well-being
Health Systems, Economic Evaluations, Quality of Life
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon